Globus Medical CEO Daniel Scavilla has resigned to take over the corner office at Dentsply Sirona, the companies announced ...

Globus Medical Inc. (NYSE:GMED) is one of the best mid cap pharma stocks to buy. On July 15, Globus Medical announced the ...

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 ...

Globus Medical will announce Q1 2025 financial results on May 8, followed by a teleconference. Quiver AI Summary Globus Medical, Inc. announced that it will release its financial results for the ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out why GMED stock is a Hold.